Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy
Clinical trial NCT01056601 · TERMINATED
Trial details
- NCT number
- NCT01056601
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-02-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.